Company Search:
Advanced Search
Sponsored Links
Dbv Technologies Company Snapshot
Dbv Technologies operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dbv Technologies with three other companies in this sector in France: Nicox SA (2018 sales of 4.03 million Euro [US$4.44 million] ), Onxeo SA (6.13 million Euro [US$6.75 million] of which 91% was Operating segment -Rest of the world), and Biocorp Sa (3.89 million Euro [US$4.28 million] of which 62% was France).

Sales Analysis. Dbv Technologies reported sales of 14.54 million Euro (US$16.01 million) for the year ending December of 2018. This represents an increase of 22.1% versus 2017, when the company's sales were 11.91 million Euro. Sales at Dbv Technologies have increased during each of the previous five years (and since 2013, sales have increased a total of 280%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dbv Technologies
  Stock Performance Chart for Dbv Technologies
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 13.68
(Figures in Euro)
1 Week 4.0%   13 Weeks 10.1%  
4 Weeks -21.0%   52 Weeks -59.9%  
Dbv Technologies Key Data:
  Ticker: DBV Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 14,537,000
(Year Ending Jan 2019).
Employees: 315
  Currency: Euro Market Cap: 494,160,246
  Fiscal Yr Ends: December Shares Outstanding: 36,122,825
  Share Type: Ordinary Closely Held Shares: 1,131,032
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.